Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparison of lopinavir level between the two formulations (soft-gel capsule and tablet) in HIV-infected pregnant women.

× No keyword cloud information.

9 in total

Review 1. Pharmacokinetic Enhancement of HIV Antiretroviral Therapy During Pregnancy.

Authors: Engie Salama; Ahizechukwu C Eke; Brookie M Best; Mark Mirochnick; Jeremiah D Momper
Journal: J Clin Pharmacol Date: 2020-08-14 Impact factor: 3.126

2. Randomized clinical trial comparing the pharmacokinetics of standard- and increased-dosage lopinavir-ritonavir coformulation tablets in HIV-positive pregnant women.

Authors: Marilia Santini-Oliveira; Rita de Cássia Elias Estrela; Valdiléa Gonçalves Veloso; Vitória Berg Cattani; Carolyn Yanavich; Luciane Velasque; Thiago Silva Torres; Luana Monteiro Spindola Marins; José Henrique Pilotto; Esaú Custódio João; José Carlos Saraiva Gonçalves; Beatriz Grinsztejn
Journal: Antimicrob Agents Chemother Date: 2014-03-10 Impact factor: 5.191

3. Improved oral bioavailability of lopinavir in melt-extruded tablet formulation reduces impact of third trimester on lopinavir plasma concentrations.

Authors: L J Else; M Douglas; L Dickinson; D J Back; S H Khoo; G P Taylor
Journal: Antimicrob Agents Chemother Date: 2011-11-21 Impact factor: 5.191

4. PHARMACOKINETIC EXPOSURE AND VIROLOGIC RESPONSE IN HIV-1 INFECTED PREGNANT WOMEN TREATED WITH LOPINAVIR/RITONAVIR: AIDS CLINICAL TRIALS GROUP PROTOCOL A5153S: A SUBSTUDY TO A5150.

Authors: Beverly E Sha; Camlin Tierney; Xin Sun; Alice Stek; Susan E Cohn; Robert W Coombs; Barbara Bastow; Francesca T Aweeka
Journal: Jacobs J AIDS HIV Date: 2015-05-16

9. New tablet formulation of tacrolimus with smaller interindividual variability may become a better treatment option than the conventional capsule formulation in organ transplant patients.

Authors: Yu Kyong Kim; Anhye Kim; Shin Jung Park; Howard Lee
Journal: Drug Des Devel Ther Date: 2017-09-28 Impact factor: 4.162

9 in total

Comparison of lopinavir level between the two formulations (soft-gel capsule and tablet) in HIV-infected pregnant women.

Review 1. Pharmacokinetic Enhancement of HIV Antiretroviral Therapy During Pregnancy.

2. Randomized clinical trial comparing the pharmacokinetics of standard- and increased-dosage lopinavir-ritonavir coformulation tablets in HIV-positive pregnant women.

3. Improved oral bioavailability of lopinavir in melt-extruded tablet formulation reduces impact of third trimester on lopinavir plasma concentrations.

4. PHARMACOKINETIC EXPOSURE AND VIROLOGIC RESPONSE IN HIV-1 INFECTED PREGNANT WOMEN TREATED WITH LOPINAVIR/RITONAVIR: AIDS CLINICAL TRIALS GROUP PROTOCOL A5153S: A SUBSTUDY TO A5150.

5. Lopinavir tablet pharmacokinetics with an increased dose during pregnancy.

6. Protein binding of lopinavir and ritonavir during 4 phases of pregnancy: implications for treatment guidelines.

Review 7. Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women.

Review 8. HIV protease inhibitors in pregnancy : pharmacology and clinical use.

9. New tablet formulation of tacrolimus with smaller interindividual variability may become a better treatment option than the conventional capsule formulation in organ transplant patients.